Instil Bio Past Earnings Performance
Past criteria checks 0/6
Instil Bio's earnings have been declining at an average annual rate of -29.4%, while the Biotechs industry saw earnings growing at 14.7% annually. Revenues have been declining at an average rate of 161.4% per year.
Key information
-29.4%
Earnings growth rate
5.6%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | -161.4% |
| Return on equity | -59.9% |
| Net Margin | n/a |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Revenue & Expenses BreakdownBeta
How Instil Bio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 0 | -123 | 50 | 26 |
| 31 Dec 23 | 0 | -156 | 51 | 39 |
| 30 Sep 23 | 0 | -197 | 57 | 54 |
| 30 Jun 23 | 0 | -186 | 62 | 85 |
| 31 Mar 23 | 0 | -226 | 67 | 118 |
| 31 Dec 22 | 0 | -223 | 69 | 137 |
| 30 Sep 22 | 0 | -225 | 64 | 160 |
| 30 Jun 22 | 0 | -211 | 60 | 149 |
| 31 Mar 22 | 0 | -188 | 57 | 129 |
| 31 Dec 21 | 0 | -157 | 51 | 104 |
| 30 Sep 21 | 0 | -119 | 44 | 74 |
| 30 Jun 21 | 0 | -83 | 33 | 50 |
| 31 Mar 21 | 0 | -57 | 21 | 31 |
| 31 Dec 20 | 0 | -38 | 13 | 18 |
Quality Earnings: TIL is currently unprofitable.
Growing Profit Margin: TIL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TIL is unprofitable, and losses have increased over the past 5 years at a rate of 29.4% per year.
Accelerating Growth: Unable to compare TIL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: TIL is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14.4%).
Return on Equity
High ROE: TIL has a negative Return on Equity (-59.91%), as it is currently unprofitable.